We are live on ! Find out more
KRRO icon

Korro Bio

41 hedge funds and large institutions have $1.67M invested in Korro Bio in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more call options, than puts

Call options by funds: $11K | Put options by funds: $1K

0.01% less ownership

Funds ownership: 0.28%0.27% (-0.01%)

5% less funds holding

Funds holding: 4341 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

34% less capital invested

Capital invested by funds: $2.52M → $1.67M (-$849K)

64% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 11

Holders
41
Holders Change
-2
Holders Change %
-4.65%
% of All Funds
0.64%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
11
Closed
6
Calls
$11K
Puts
$1K
Net Calls
+$10K
Net Calls Change
+$25K

KRRO Hedge Fund Activity: Q2 2023 in Review

41 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q2 2023, worth a combined $1.67M — down 34% from $2.52M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of KRRO and 4 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 4 added.

The largest buyer was Millennium Management, adding an estimated $13.2K. The largest seller was Susquehanna International Group, cutting an estimated $37K.

  • 41 institutional investors held Korro Bio (KRRO) as of Q2 2023, down from 43 in Q1 2023.
  • Funds reported $1.67M of Korro Bio stock for Q2 2023, down 34% quarter-over-quarter.
  • 4 funds opened new Korro Bio positions in Q2 2023 and 6 closed out, a net change of -2 holders.
  • The largest Korro Bio buyer in Q2 2023 was Millennium Management, an estimated $13.2K added.
  • The largest Korro Bio seller in Q2 2023 was Susquehanna International Group, an estimated $37K sold.

Based on aggregated 13F filings for Q2 2023.